US Stock MarketDetailed Quotes

NKTR Nektar Therapeutics

Watchlist
  • 0.9342
  • +0.0491+5.55%
Close Mar 28 16:00 ET
  • 0.9200
  • -0.0142-1.52%
Post 19:16 ET
171.54MMarket Cap-644P/E (TTM)

About Nektar Therapeutics Company

Nektar Therapeutics is a research-based biopharmaceutical company which engages in discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology. The firm focuses on using new chemistry approaches to make medicines to treat cancer and autoimmune diseases. The company was founded in 1990 and is headquartered in San Francisco, CA.

Company Profile

SymbolNKTR
Company NameNektar Therapeutics
Listing Date05/06/1994
Issue Price7.50
Founded1990
CEOMr. Howard W. Robin
MarketNASDAQ
Employees137
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address455 Mission Bay Boulevard South
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94158
Phone1-415-482-5300

Company Executives

  • Name
  • Position
  • Salary
  • Howard W. Robin
  • Director, President and Chief Executive Officer
  • 11.15M
  • Sandra A. Gardiner
  • Interim Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Jonathan Zalevsky, PhD
  • Chief Research and Development Officer
  • 4.95M
  • Mark Andrew Wilson, J.D.
  • Senior Vice President and Chief Legal Officer
  • 3.50M
  • Robert B. Chess
  • Chairman of the Board
  • 501.96K
  • R. Scott Greer
  • Independent Director
  • 490.96K
  • Roy A. Whitfield
  • Lead Independent Director
  • 500.96K
  • Jeffrey R. Ajer
  • Independent Director
  • 469.96K
  • Dr. Myriam J. Curet, M.D.
  • Independent Director
  • 453.96K
  • Dr. Diana M. Brainard, M.D.
  • Independent Director
  • 544.80K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg